Nifedipine and oncologic Raynaud phenomenon.
Hantel
A
A
Rowinsky
E K
EK
Donehower
R C
RC
D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D008297:Male; D009543:Nifedipine / Q000627:therapeutic use*; D011928:Raynaud Disease / Q000139:chemically induced / Q000188:drug therapy*; D013736:Testicular Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D009543:Nifedipine